A Study of RO5036505 in Patients With Moderate to Severe Asthma

NCT00967590 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped No patients dosed

Conditions

Asthma

Interventions

DRUG: RO5036505
DRUG: placebo

Sponsor

Hoffmann-La Roche